C96.29
Other malignant mast cell neoplasm
Clinical Classification Guidelines
Medical Intelligence & Overview
Other malignant mast cell neoplasm refers to a rare form of cancer originating from mast cells, which are a type of immune cell involved in allergic responses and inflammation. This condition is categorized under ICD-10 code C96.29 and includes various malignant tumors of mast cells that do not fit into more common classifications. These neoplasms can occur in different parts of the body and may exhibit aggressive behavior, requiring careful diagnosis and management.
Causes & Symptoms
Clinical Causes: Genetic mutations leading to abnormal mast cell growth Certain inherited syndromes that predispose to mast cell proliferations Environmental factors that may trigger malignant transformation Unknown factors in many cases, as the exact cause remains unclear
Key Symptoms: Skin reactions such as redness, swelling, or rashes Itching, often severe Swelling of lymph nodes or other tissues Unexplained pain or discomfort in affected areas Weight loss and fatigue in advanced cases Anemia or bleeding tendencies if bone marrow is involved Gastrointestinal symptoms like nausea, diarrhea, or abdominal pain
Diagnostic & Treatment
Diagnosis Path: Medical history and physical examination focusing on skin and other affected areas Blood tests to identify abnormal mast cell marker levels Biopsy of suspected lesion or involved tissue for microscopic examination Immunohistochemistry to detect specific mast cell markers such as tryptase and CD117 Imaging studies like CT or MRI to assess the extent and spread of the disease Molecular testing for genetic mutations associated with mast cell neoplasms
Treatment Protocols: Chemotherapy to target rapidly dividing cells Targeted therapy using medications like tyrosine kinase inhibitors Radiation therapy in localized cases or to palliate symptoms Supportive treatments such as antihistamines and corticosteroids to control allergic symptoms Surgical removal of accessible tumors Stem cell transplantation in selected cases Close follow-up and monitoring for disease progression or recurrence
Clinical Advice & FAQs
Billing Guidance
Is C96.29 a billable ICD-10 code?
Yes, C96.29 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C96.29?
Clinical documentation must specify the nature of Other malignant mast cell neoplasm and any associated comorbidities for accurate reporting.
Cite this Clinical Reference